This video is sponsored by the Duke Clinical Medical Series.
Topics include:
* Diabetes Mellitus and ACS
* DM in ACS: How Common?
* Glucometabolic State in Non-DM CAD Admissions
* European Heart Survey on DM 110 Centers; 25 ESC Member Countries
* Canadian Trends: DM and CVD
* DM in ACS: How Common?
* Short- and Long-term Risk
* Crude Mortality
* DM and Short- and Long-term Mortality in ACS
* 7-year Mortality by Age
he moderator, Kristin Newby, MD, has indicated that she receives research/grant support
from Bristol-Myers Squibb, Sanofi, Millennium Pharmaceuticals, Inc., Schering-Plough
Research Institute, Novartis and Roche Diagnostics Corporation. Dr. Newby is also a member
of an advisory board for Eli Lilly and a consultant for Proctor and Gamble; she has spoken
at scientific symposia for Aventis, Bristol-Myers Squibb, Sanofi and Millennium
Pharmaceuticals, Inc.
The guest faculty, Professor Mikael Dellborg, has indicated that he has no industry
relationships to disclose.
|
|